Vicarious Surgical Inc. (RBOT)
| Bid | 7.45 |
| Market Cap | 46.89M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -61.62M |
| EPS (ttm) | -10.84 |
| PE Ratio (ttm) | -0.73 |
| Forward PE | -1.23 |
| Analyst | Hold |
| Ask | 8.39 |
| Volume | 8,888 |
| Avg. Volume (20D) | 17,782 |
| Open | 8.38 |
| Previous Close | 8.70 |
| Day's Range | 7.91 - 8.38 |
| 52-Week Range | 4.27 - 19.00 |
| Beta | 1.42 |
About RBOT
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for RBOT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
2 months ago · businesswire.com
Vicarious Surgical Receives Continued Listing Standard Notice from the NYSEWALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
2 months ago · businesswire.com
Vicarious Surgical Announces President Transition to Board Member RoleWALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
3 months ago · businesswire.com
Vicarious Surgical Reports Fourth Quarter and Full Year 2024 Financial ResultsWALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...